循环c-Met阳性记忆T细胞定义心脏自身免疫
该研究通过对外周血T细胞(包括c-Met+ T细胞)进行深度表型分析,发现c-Met+ T细胞在炎症性心肌病患者循环和心肌中选择性增多,其表型和功能与c-Met- T细胞不同,能优先对心肌肌球蛋白增殖并产生多种细胞因子。在实验性自身免疫性心肌炎中,外周血自身抗原特异性c-Met+ T细胞升高标志对心脏免疫耐受的丧失,药物抑制c-Met可阻止疾病发展。
要点
- 炎症性心肌病患者循环和心肌中c-Met+ T细胞选择性增多。
- c-Met+ T细胞优先对心肌肌球蛋白增殖并产生IL-4、IL-17和IL-22。
- 实验性自身免疫性心肌炎中,药物抑制c-Met可阻止疾病发展。
核心结论
- 检测循环c-Met+ T细胞可能用于适应性心脏炎症的诊断和监测,并为心脏自身免疫导致的进行性心脏损伤提供新的治疗靶点。
研究设计与样本
- 研究对炎症性和非炎症性心肌病患者、非心脏自身免疫患者及健康对照的外周血T细胞(包括c-Met+ T细胞)进行深度表型分析,并利用人心肌组织和实验性心脏炎症模型进行验证。
主要发现
- c-Met+ T细胞在炎症性心肌病患者的循环和心肌中选择性增多。
- c-Met+ T细胞的表型和功能与c-Met- T细胞不同,包括优先对心肌肌球蛋白增殖和共产生多种细胞因子(IL-4、IL-17和IL-22)。
- 不同心脏肌肉疾病中循环c-Met+ T细胞亚群识别出心脏炎症的不同和重叠机制。
- 在实验性自身免疫性心肌炎中,外周血自身抗原特异性c-Met+ T细胞升高标志对心脏免疫耐受的丧失。
- 药物抑制c-Met可阻止疾病发展,表明c-Met+ T细胞具有致病作用。
临床怎么用
- 检测循环c-Met+ T细胞可能有助于诊断和监测适应性心脏炎症。
- c-Met+ T细胞可能成为心脏自身免疫治疗干预的新靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autoimmunity is increasingly recognized as a key contributing factor in heart muscle diseases. The functional features of cardiac autoimmunity in humans remain undefined because of the challenge of studying immune responses in situ. We previously described a subset of c-mesenchymal epithelial transition factor (c-Met)-expressing (c-Met+) memory T lymphocytes that preferentially migrate to cardiac tissue in mice and humans. METHODS: In-depth phenotyping of peripheral blood T cells, including c-Met+ T cells, was undertaken in groups of patients with inflammatory and noninflammatory cardiomyopathies, patients with noncardiac autoimmunity, and healthy controls. Validation studies were carried out using human cardiac tissue and in an experimental model of cardiac inflammation. RESULTS: We show that c-Met+ T cells are selectively increased in the circulation and in the myocardium of patients with inflammatory cardiomyopathies. The phenotype and function of c-Met+ T cells are distinct from those of c-Met-negative (c-Met-) T cells, including preferential proliferation to cardiac myosin and coproduction of multiple cytokines (interleukin-4, interleukin-17, and interleukin-22). Furthermore, circulating c-Met+ T cell subpopulations in different heart muscle diseases identify distinct and overlapping mechanisms of heart inflammation. In experimental autoimmune myocarditis, elevations in autoantigen-specific c-Met+ T cells in peripheral blood mark the loss of immune tolerance to the heart. Disease development can be halted by pharmacologic c-Met inhibition, indicating a causative role for c-Met+ T cells. CONCLUSIONS: Our study demonstrates that the detection of circulating c-Met+ T cells may have use in the diagnosis and monitoring of adaptive cardiac inflammation and definition of new targets for therapeutic intervention when cardiac autoimmunity causes or contributes to progressive cardiac injury.
引用
- Fanti S, Stephenson E, Rocha-Vieira E, et al. Circulating c-Met-Expressing Memory T Cells Define Cardiac Autoimmunity. Circulation. 2022. PMID: 36417924. doi:10.1161/CIRCULATIONAHA.121.055610
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。